The Daya Foundation and Knopf Laboratories, two Chilean institutions specializing in the therapeutic use of marijuana, presented Tuesday their joint project for the first Latin American study on the use of medical marijuana to ease the pain of breast and lung cancer.
"The clinical trial is designed to test the efficacy and security of a cannabis-based pharmaceutical for patients with breast or lung cancer. It is a very relevant study because it means Chile will be leading the way to the democratization of medical marijuana," Ana Maria Gazmuri, president of the Daya Foundation, told EFE.
Source: EFE
Nenhum comentário:
Postar um comentário